Plan to set up multi-million shilling vaccine plant in top gear

Kenya will start construction of a multi-million-shilling vaccine manufacturing plant before the end of this year, following approval of funding from the World Bank.

Kenya BioVax Institute —the agency tasked with setting up the facility– disclosed that the World Bank has approved the funding, estimated at $120 million (Sh15.7 billion).